- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/4 | 6.55 | -8.61 | 4.93 | 29.35 | 0.26 | 20.38 | N/A | - | ||
| 2026/3 | 7.16 | 7.33 | -4.93 | 22.8 | -0.99 | 22.8 | 0.75 | - | ||
| 2026/2 | 6.67 | -25.56 | 0.36 | 15.64 | 0.91 | 24.93 | 0.69 | - | ||
| 2026/1 | 8.96 | -3.53 | 1.33 | 8.96 | 1.33 | 25.94 | 0.66 | - | ||
| 2025/12 | 9.29 | 20.95 | 8.88 | 88.64 | 0.06 | 24.38 | 0.7 | - | ||
| 2025/11 | 7.68 | 3.76 | 11.82 | 79.35 | -0.87 | 22.32 | 0.77 | - | ||
| 2025/10 | 7.4 | 2.31 | 0.1 | 71.67 | -2.06 | 21.61 | 0.79 | - | ||
| 2025/9 | 7.24 | 3.77 | 31.63 | 64.26 | -2.3 | 21.47 | 0.78 | - | ||
| 2025/8 | 6.97 | -3.9 | -18.91 | 57.02 | -5.4 | 21.21 | 0.78 | - | ||
| 2025/7 | 7.26 | 3.97 | -10.63 | 50.05 | -3.15 | 20.78 | 0.8 | - | ||
| 2025/6 | 6.98 | 6.61 | -17.53 | 42.79 | -1.75 | 19.76 | 0.77 | - | ||
| 2025/5 | 6.55 | 4.94 | -7.97 | 35.81 | 2.04 | 20.32 | 0.75 | - | ||
| 2025/4 | 6.24 | -17.21 | -17.69 | 29.27 | 4.59 | 20.42 | 0.75 | - | ||
| 2025/3 | 7.53 | 13.32 | 14.65 | 23.03 | 12.87 | 23.03 | 0.69 | - | ||
| 2025/2 | 6.65 | -24.84 | 5.1 | 15.5 | 12.02 | 24.03 | 0.67 | - | ||
| 2025/1 | 8.85 | 3.65 | 17.86 | 8.85 | 17.86 | 24.25 | 0.66 | - | ||
| 2024/12 | 8.54 | 24.22 | 1.72 | 88.58 | 10.87 | 22.8 | 0.74 | - | ||
| 2024/11 | 6.87 | -7.11 | 4.83 | 80.05 | 11.94 | 19.77 | 0.85 | - | ||
| 2024/10 | 7.4 | 34.54 | 5.19 | 73.17 | 12.66 | 21.5 | 0.78 | - | ||
| 2024/9 | 5.5 | -36.07 | -16.47 | 65.78 | 13.57 | 22.22 | 0.73 | - | ||
| 2024/8 | 8.6 | 5.9 | 26.05 | 60.28 | 17.42 | 25.18 | 0.65 | - | ||
| 2024/7 | 8.12 | -4.04 | 22.68 | 51.68 | 16.09 | 23.7 | 0.69 | - | ||
| 2024/6 | 8.46 | 18.97 | 14.21 | 43.56 | 14.95 | 23.16 | 0.65 | - | ||
| 2024/5 | 7.11 | -6.13 | 11.95 | 35.1 | 15.12 | 21.26 | 0.7 | - | ||
| 2024/4 | 7.58 | 15.31 | 33.31 | 27.98 | 15.96 | 20.48 | 0.73 | - | ||
| 2024/3 | 6.57 | 3.88 | 7.35 | 20.4 | 10.61 | 20.4 | N/A | - | ||
| 2024/2 | 6.33 | -15.72 | 10.59 | 13.83 | 12.23 | 22.22 | N/A | - | ||
| 2024/1 | 7.51 | -10.53 | 13.66 | 7.51 | 13.66 | 22.45 | N/A | - | ||
| 2023/12 | 8.39 | 28.01 | 21.65 | 79.89 | -10.5 | 21.98 | N/A | - | ||
| 2023/11 | 6.55 | -6.79 | 5.29 | 71.5 | -13.2 | 20.17 | N/A | - | ||
| 2023/10 | 7.03 | 6.83 | 8.73 | 64.95 | -14.71 | 20.44 | N/A | - | ||
| 2023/9 | 6.58 | -3.52 | -12.28 | 57.92 | -16.88 | 20.02 | N/A | - | ||
| 2023/8 | 6.82 | 3.07 | -9.61 | 51.34 | -17.44 | 20.85 | N/A | - | ||
| 2023/7 | 6.62 | -10.66 | -7.17 | 44.51 | -18.52 | 20.38 | N/A | - | ||
| 2023/6 | 7.41 | 16.62 | -5.38 | 37.89 | -20.22 | 19.45 | N/A | - | ||
| 2023/5 | 6.35 | 11.76 | -50.82 | 30.48 | -23.15 | 18.16 | N/A | 因子公司杏昌生技去年同期有新增快篩試劑銷售本年度因疫情趨緩銷售減少 | ||
| 2023/4 | 5.68 | -7.13 | -4.67 | 24.13 | -9.79 | 17.53 | N/A | - | ||
| 2023/3 | 6.12 | 7.01 | -15.03 | 18.45 | -11.27 | 18.45 | N/A | - | ||
| 2023/2 | 5.72 | -13.38 | 6.95 | 12.32 | -9.27 | 19.22 | N/A | - | ||
| 2023/1 | 6.6 | -4.24 | -19.81 | 6.6 | -19.81 | 19.73 | N/A | - | ||
| 2022/12 | 6.9 | 10.79 | -14.11 | 89.28 | 8.55 | 19.59 | N/A | - | ||
| 2022/11 | 6.22 | -3.74 | -6.51 | 82.38 | 11.01 | 20.2 | N/A | - | ||
| 2022/10 | 6.47 | -13.81 | -17.23 | 76.15 | 12.73 | 21.52 | N/A | - | ||
| 2022/9 | 7.5 | -0.58 | -3.11 | 69.69 | 16.65 | 22.18 | N/A | - | ||
| 2022/8 | 7.55 | 5.85 | 0.3 | 62.18 | 19.6 | 22.51 | N/A | - | ||
| 2022/7 | 7.13 | -8.94 | 19.04 | 54.63 | 22.87 | 27.88 | N/A | - | ||
| 2022/6 | 7.83 | -39.38 | 10.7 | 47.5 | 23.46 | 26.72 | N/A | - | ||
| 2022/5 | 12.92 | 116.65 | 122.0 | 39.67 | 26.33 | 26.09 | N/A | 合併子公司杏昌生技業務增加 | ||
| 2022/4 | 5.96 | -17.22 | -14.0 | 26.75 | 4.57 | 18.52 | N/A | - | ||
| 2022/3 | 7.2 | 34.71 | 5.36 | 20.79 | 11.48 | 20.79 | N/A | - | ||
| 2022/2 | 5.35 | -35.06 | -6.59 | 13.58 | 15.03 | 21.61 | N/A | - | ||
| 2022/1 | 8.24 | 2.55 | 35.39 | 8.24 | 35.39 | 22.92 | N/A | - | ||
| 2021/12 | 8.03 | 20.59 | 22.38 | 82.24 | 24.88 | 22.5 | N/A | - | ||
| 2021/11 | 6.66 | -14.77 | 20.58 | 74.21 | 25.16 | 22.22 | N/A | 貿易出貨成長 | ||
| 2021/10 | 7.81 | 0.88 | 63.63 | 67.55 | 25.63 | 23.08 | N/A | 貿易營收成長 | ||
| 2021/9 | 7.75 | 2.91 | 35.93 | 59.74 | 21.93 | 21.26 | N/A | - | ||
| 2021/8 | 7.53 | 25.63 | 26.54 | 51.99 | 20.08 | 20.59 | N/A | 貿易出貨成長 | ||
| 2021/7 | 5.99 | -15.32 | 6.39 | 44.46 | 19.06 | 18.88 | N/A | - | ||
| 2021/6 | 7.07 | 21.55 | 15.45 | 38.48 | 21.3 | 0.0 | N/A | - | ||
| 2021/5 | 5.82 | -16.08 | 11.16 | 31.4 | 22.71 | 0.0 | N/A | - |
| 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
|---|---|---|---|---|---|---|---|---|---|
| 2026/1 | 8.96 | 2025/1 | 8.85 | 2024/1 | 7.51 | 2023/1 | 6.6 | 2022/1 | 8.24 |
| 2026/2 | 6.67 | 2025/2 | 6.65 | 2024/2 | 6.33 | 2023/2 | 5.72 | 2022/2 | 5.35 |
| 2026/3 | 7.16 | 2025/3 | 7.53 | 2024/3 | 6.57 | 2023/3 | 6.12 | 2022/3 | 7.2 |
| 2026/4 | 6.55 | 2025/4 | 6.24 | 2024/4 | 7.58 | 2023/4 | 5.68 | 2022/4 | 5.96 |
| N/A | N/A | 2025/5 | 6.55 | 2024/5 | 7.11 | 2023/5 | 6.35 | 2022/5 | 12.92 |
| N/A | N/A | 2025/6 | 6.98 | 2024/6 | 8.46 | 2023/6 | 7.41 | 2022/6 | 7.83 |
| N/A | N/A | 2025/7 | 7.26 | 2024/7 | 8.12 | 2023/7 | 6.62 | 2022/7 | 7.13 |
| N/A | N/A | 2025/8 | 6.97 | 2024/8 | 8.6 | 2023/8 | 6.82 | 2022/8 | 7.55 |
| N/A | N/A | 2025/9 | 7.24 | 2024/9 | 5.5 | 2023/9 | 6.58 | 2022/9 | 7.5 |
| N/A | N/A | 2025/10 | 7.4 | 2024/10 | 7.4 | 2023/10 | 7.03 | 2022/10 | 6.47 |
| N/A | N/A | 2025/11 | 7.68 | 2024/11 | 6.87 | 2023/11 | 6.55 | 2022/11 | 6.22 |
| N/A | N/A | 2025/12 | 9.29 | 2024/12 | 8.54 | 2023/12 | 8.39 | 2022/12 | 6.9 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
| 合約負債 QoQ YoY | |||
|---|---|---|---|
| 26Q1 (8) | 0.62 | -62.42 | 67.57 |
| 25Q4 (7) | 1.65 | 81.32 | 302.44 |
| 25Q3 (6) | 0.91 | 97.83 | 111.63 |
| 25Q2 (5) | 0.46 | 24.32 | 2.22 |
| 25Q1 (4) | 0.37 | -9.76 | 0.0 |
| 24Q4 (3) | 0.41 | -4.65 | 0.0 |
| 24Q3 (2) | 0.43 | -4.44 | 0.0 |
| 24Q2 (1) | 0.45 | 0.0 | 0.0 |